ArticleFrontiers in psychiatry2026
Exploring the influencing factors of initial seizure time during modified electroconvulsive therapy in patients under 30 years old with mental disorders.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the factors influencing the initial seizure duration during modified electroconvulsive therapy (MECT) in patients under 30 years old with mental disorders and propose optimized initial treatment parameters for this population. Methods: A total of 287 patients were included. Six features-preset energy percentage, etomidate dose, gender, age, antiepileptic drug usage, and disease type (depression, bipolar disorder, schizophrenia)-were used to build a classification model predicting whether seizure duration was ideal (15-75 seconds) or non-ideal. Data preprocessing included one-hot encoding for categorical variables and Z-score normalization for continuous variables. Synthetic Minority Over-sampling Technique (SMOTE) was applied to balance the dataset. A random forest classification model with five-fold cross-validation was used to analyze feature importance. Results: The model achieved average precision of 76.9%, recall of 75.1%, and F1-score of 74.4%. Age (importance coefficient: 0.338), energy percentage (0.252), and etomidate dose (0.208) were the core influencing factors, collectively contributing >79% of explanatory power. Disease type, antiepileptic drug usage, and gender had minimal impacts. Conclusion: For patients under 30 years old, age, energy percentage, and etomidate dose were the most critical predictors of ideal seizure time during initial MECT, while disease type, antiepileptic drug use, and gender had minimal impact. We recommend setting the initial energy percentage to 1/3-2/5 of the patient's age, combined with etomidate dose adjustment, to effectively optimize seizure duration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.